Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new ... Researchers Develop Analytical Pipeline to Identify ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A study found that those with upper gastrointestinal damage are 76% more likely to develop Parkinson's disease, signaling a ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Minneapolis: According to a study, a class of diabetes medications may be linked to a decreased risk of dementia and Parkinson's disease. The findings were published in the online edition of ...

The results of these findings were recently published in Molecular Psychiatry. Treatment of Parkinson's disease is in large part based on the administration of levodopa. The use of this drug is ...

chronic (long-term) respiratory disease, such as asthma (requires continuous or repeated use of inhaled or systemic steroids ...

You can get the free NHS flu vaccine from October 3 if you fit the following: those living in long-stay residential care ...